These results indicate that TRIP13 knockdown inhibits the expression of PCNA and Ki-67 and enhances the expression of E-cadherin, thereby inhibiting the proliferation and migration of ccRCC cells in vivo. Here, PCNA is linked to nonpapillary renal cell carcinoma.